"Dexcom's Glucose Monitor Use Shows Benefit in Non-Insulin Diabetic Patients in Study."
June 2026
Reuters
Tamara K. Oser, MD, Professor of Family Medicine at CU Anschutz, is the Principal Investigator for a landmark research trial, “CGM for Adults with Type 2 Diabetes Not on Insulin: The CONNECT Randomized Controlled Trial.” Results were presented on June 6, at the 2026 Scientific Sessions of the American Diabetes Association (ADA) in New Orleans.
The ADA’s Scientific Sessions is the largest and most prominent conference in the world focused on diabetes—bringing together research, clinical care, and innovation. After the conference, a Reuters article, “Dexcom's Glucose Monitor Use Shows Benefit in Non-Insulin Diabetic Patients in Study,” highlighted results presented at the conference, noting that this research "will help establish a new standard of care in the U.S. and around the world.”
The CONNECT study is the first research trial to demonstrate the benefit of continuous glucose monitoring (CGM) for people with type 2 diabetes who are not using insulin. When asked what this work means to her, Dr. Oser expressed her passion for diabetes research and her excitement about the findings’ potential to substantially influence the standard of care and improve access for people with type 2 diabetes.
“As a family physician and director of the Primary Care Diabetes Lab (PCDL), this work is incredibly meaningful to me. Despite advances in treatment, many people with diabetes still do not meet glycemic targets. This study provides level A evidence that CGM offers both clinical and psychosocial benefits for people with type 2 diabetes—even if they are not on insulin. The PCDL is dedicated to ensuring that all people can access the best possible diabetes care wherever they receive it, and this study provides strong evidence to change the ADA Standards of Care and expand access to CGM.”
Congratulations to Dr. Oser on this monumental moment!
Read more in Reuters, and in the published abstract, and note that more information will be shared when the study is fully published.